Author: OurCrowd

[Hyperloop One in Inverse] Hyperloop One is coming to Europe with these 10 proposed routes

May 17, 2017 |

Hyperloop One, the only company in the world with a full-size hyperloop test track, is coming to Europe. On Tuesday, the company announced that it will continue its global tour with a stop in Amsterdam on June 6, a chance to detail a number of routes for the continent. Elon Musk released his idea for a vacuum-sealed train system back in 2013, with theoretical top speeds of 700 miles per hour, but so far no publicly accessible hyperloop tracks exist. Hyperloop One is confident it will be the first to bring the system to life: it’s spent the past year working on the DevLoop test track in the Nevada desert, and it hopes to hold its first public demonstration (which it refers to as its “Kitty Hawk moment”) in the next month or so. Read more on Inverse...

Read More

[Centaur in PCMag] 13 inventive startups making noise at TechCrunch Disrupt

May 17, 2017 |

Centaur is a post-harvest Internet of Things (IoT) platform for transporting and tracking crops. The IoT is already making a significant impact in agricultural efficiency, but Centaur extends that data-driven process by equipping shipping containers with sensors and employing analytics to predict for factors such as crop spoilage and infestation controlled through a real-time web dashboard and mobile app. Based in Greece with a sales office in California, Centaur can also recommend sustainability practices, treatment plans, and environmentally friendly procedures for tasks like pest fumigation. Read more on PCMag...

Read More

[MedAware in FiercePharma] MedAware’s script-error tool for docs could help marketers plenty, too, CEO says

May 17, 2017 |

Med mix-ups are a dangerous problem–and one Israel’s MedAware is working to address with an intelligent system that calls out would-be prescription errors based on doc-habit data and information from patients’ own medical records. In collecting that info, though, MedAware’s system also picked up key data on prescribing patterns that has the potential to be very valuable to pharma marketers. The company has aggregated millions of prescriptions and full medical records—including blood tests, diagnoses, admissions, outpatient visits and more—to create mathematical models that describe which patients are likely to be prescribed which drugs, and at what point in their condition and treatment, cofounder and CEO Gidi Stein explained in an interview. Read more on FiercePharma...

Read More

[BioCatch in MarketWatch] Americans are more likely to pay digital ransoms after cyberattacks

May 16, 2017 |

So why are cyberattack on this scale? And why now? “We believe ransomware is often directed at organizations because the payout is higher and in many cases, it is often cheaper to pay the ransom than attempt to combat the attack,” said Frances Zelazny, vice president of cybersecurity company BioCatch. “There is a shortage of personnel with cybersecurity expertise and this makes organizations that much more vulnerable, which makes more of a case for building resilience and real-time response.” Read more on MarketWatch...

Read More

[Nanorep in The Australian] Nanorep eyes Australian shores

May 16, 2017 |

Israeli smart bot solutions provider Nanorep is looking to make inroads in the Australian market with senior executive Mark Granot confident that its technology can shake up the local self-service market. Nanorep’s vice president of Alliances and Partners, Mark Granot, said that the continued evolution of virtual assistants is forcing businesses to rethink their approaches to customer service. Read more on The Australian...

Read More